|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6883 |
| (11) | Patento numeris | 3174995 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15742250.2 |
| Europos patento paraiškos padavimo data | 2015-07-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/067098 |
| Data | 2015-07-27 |
| (87) | Numeris | WO 2016/016157 |
| Data | 2016-02-04 |
| (30) | Numeris | Data | Šalis |
| 14179048 | 2014-07-30 | EP |
| (72) |
DUBÉ, Marie-Pierre, CA
TARDIF, Jean-Claude, CA
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY WITH HDL-RAISING OR HDL MIMICKING AGENT |
| GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY WITH HDL-RAISING OR HDL MIMICKING AGENT |